BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 2825939)

  • 1. Abnormal regulation of the sympathoadrenal system in deoxycorticosterone acetate-salt hypertensive rats.
    de Champlain J; Bouvier M; Drolet G
    Can J Physiol Pharmacol; 1987 Aug; 65(8):1605-14. PubMed ID: 2825939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acute and chronic administration of sotalol on the blood pressure and the sympathoadrenal activity of anesthetized deoxycorticosterone acetate-salt hypertensive rats.
    Bouvier M; de Champlain J
    Can J Physiol Pharmacol; 1986 Sep; 64(9):1164-9. PubMed ID: 3779515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased sympatho-adrenal tone and adrenal medulla reactivity in DOCA-salt hypertensive rats.
    Bouvier M; de Champlain J
    J Hypertens; 1986 Apr; 4(2):157-63. PubMed ID: 3011889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperresponsiveness of sympathoadrenal system in conscious DOCA-NaCl and SHR rats in response to acute hemorrhagic hypotension.
    Drolet G; de Champlain J
    Clin Invest Med; 1992 Aug; 15(4):360-70. PubMed ID: 1516293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced sympathoadrenal reactivity to haemorrhagic stress in DOCA-salt hypertensive rats.
    Drolet G; Bouvier M; de Champlain J
    J Hypertens; 1989 Mar; 7(3):237-42. PubMed ID: 2708820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of prejunctional alpha 2-adrenergic autoinhibition in DOCA-salt hypertension.
    Moreau P; Drolet G; Yamaguchi N; de Champlain J
    Am J Hypertens; 1995 Mar; 8(3):287-93. PubMed ID: 7794579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin enhances and inhibits adrenal catecholamine release in deoxycorticosterone acetate-salt hypertensive rats.
    Lange DL; Haywood JR; Hinojosa-Laborde C
    Hypertension; 2000 Jan; 35(1 Pt 2):385-90. PubMed ID: 10642329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased basal and reactive plasma norepinephrine and epinephrine levels in awake DOCA-salt hypertensive rats.
    Bouvier M; de Champlain J
    J Auton Nerv Syst; 1986 Feb; 15(2):191-5. PubMed ID: 3958436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of presynaptic beta 2-adrenergic facilitation in the development and maintenance of DOCA-salt hypertension.
    Moreau P; Drolet G; Yamaguchi N; de Champlain J
    Am J Hypertens; 1993 Dec; 6(12):1016-24. PubMed ID: 7907884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced depressor effect of bromocriptine in the DOCA/NaCl hypertensive rat.
    Nagahama S; Chen YF; Oparil S
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H64-70. PubMed ID: 2861750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral neurogenic mechanisms in deoxycorticosterone acetate--salt hypertension in the rat.
    de Champlain J; Eid H; Drolet G; Bouvier M; Foucart S
    Can J Physiol Pharmacol; 1989 Sep; 67(9):1140-5. PubMed ID: 2688861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced depressor effect of muscimol in the DOCA/NaCl hypertensive rat: evidence for altered GABAergic activity in brain.
    Nagahama S; Dawson R; Oparil S
    Proc Soc Exp Biol Med; 1985 Nov; 180(2):277-83. PubMed ID: 4048165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red blood cell catecholamine levels in normotensive and DOCA-salt hypertensive rats.
    Bouvier M; Farley L; de Champlain J
    Am J Physiol; 1987 Aug; 253(2 Pt 2):H270-5. PubMed ID: 3618801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective activation of the adrenal medulla during acute bilateral carotid occlusion and its modulation by alpha-adrenergic receptors in the rat.
    Bouvier M; de Champlain J
    Can J Physiol Pharmacol; 1983 Apr; 61(4):381-7. PubMed ID: 6305467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of norepinephrine release by presynaptic alpha 2-adrenoceptors in mesenteric vasculature preparations from chronic DOCA-salt hypertensive rats.
    Tsuda K; Tsuda S; Nishio I; Masuyama Y
    Jpn Heart J; 1989 Mar; 30(2):231-9. PubMed ID: 2542635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperresponsiveness of monoaminergic mechanisms in DOCA/NaCl hypertensive rats.
    Chen YF; Nagahama S; Winternitz SR; Oparil S
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H71-9. PubMed ID: 4014487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced presynaptic beta 2-adrenergic facilitatory mechanism in conscious deoxycorticosterone acetate-salt hypertensive rats.
    Moreau P; de Champlain J; Yamaguchi N
    J Hypertens Suppl; 1991 Dec; 9(6):S68-9. PubMed ID: 1668014
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased apparent norepinephrine release rate in anesthetized DOCA-salt hypertensive rats.
    Bouvier M; de Champlain J
    Clin Exp Hypertens A; 1985; 7(11):1629-45. PubMed ID: 4085138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the adrenal medullae in male and female DOCA-salt hypertensive rats.
    Lange DL; Haywood JR; Hinojosa-Laborde C
    Hypertension; 1998 Jan; 31(1 Pt 2):403-8. PubMed ID: 9453336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypotensive action of taurine in DOCA-salt rats--involvement of sympathoadrenal inhibition and endogenous opiate.
    Sato Y; Ogata E; Fujita T
    Jpn Circ J; 1991 May; 55(5):500-8. PubMed ID: 2062001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.